Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2026-2030

Market Size (2024)

USD 1.93 Billion

CAGR (2025-2030)

6.33%

Fastest Growing Segment

Female

Largest Market

North America

Market Size (2030)

USD 2.79 Billion

Market Overview

The Global Platysmaplasty Treatment Market, valued at USD 1.93 Billion in 2024, is projected to experience a CAGR of 6.33% to reach USD 2.79 Billion by 2030. Platysmaplasty, a surgical procedure designed to enhance the neck and jawline by tightening the platysma muscles and addressing sagging skin, forms a key segment of the aesthetic market. Main drivers supporting its growth include increasing global aesthetic consciousness, a growing aging demographic seeking rejuvenation, and continuous advancements in surgical techniques that offer refined outcomes. According to the International Society of Aesthetic Plastic Surgery (ISAPS), 452,639 neck lift procedures were performed globally in 2023, representing a 13.0% increase from 2022.

Despite these growth factors, a significant challenge impeding market expansion is the high cost associated with these elective procedures, which can limit accessibility for a considerable consumer base.

Key Market Drivers

The increasing global geriatric population represents a substantial driver for the platysmaplasty treatment market. As individuals live longer and maintain a desire for a rejuvenated appearance, the demand for procedures addressing age-related changes in the neck and jawline naturally escalates. This demographic actively seeks solutions to combat visible signs of aging, such as platysmal banding and skin laxity, which become more pronounced with advancing years. According to the World Health Organization, in February 2025, its 'Ageing: Global population' report indicated the number of people aged 60 and older worldwide was 1.1 billion in 2023, projected to reach 1.4 billion by 2030. This demographic shift directly contributes to an expanding clientele for platysmaplasty.

Concurrently, continuous advancements in surgical techniques and technology are instrumental in expanding the platysmaplasty market. Innovations offer more precise, effective, and minimally invasive options, enhancing patient safety and satisfaction while reducing recovery times. Refined surgical approaches allow for tailored outcomes, addressing individual patient concerns with greater accuracy. According to the American Academy of Facial Plastic and Reconstructive Surgery AAFPRS 2023 member survey outcomes, published in February 2024, AAFPRS members performed an average of 48 facelifts or partial facelifts in 2023, demonstrating a 60 percent increase since 2017. This growth in related surgical procedures underscores technological progress's positive impact on patient acceptance and procedural volume within facial aesthetics. Furthermore, the broader aesthetic industry continues to experience robust demand; according to the American Society of Plastic Surgeons, in 2023, over 28 million surgical and minimally-invasive cosmetic and reconstructive procedures were performed in the United States. These advancements collectively make platysmaplasty a more accessible and desirable option.


Download Free Sample Report

Key Market Challenges

A significant challenge impeding the expansion of the Global Platysmaplasty Treatment Market is the high cost associated with these elective procedures. Platysmaplasty, like most aesthetic surgical interventions, is typically not covered by health insurance, placing the entire financial burden on the patient. This substantial out-of-pocket expense acts as a formidable barrier, directly limiting accessibility for a considerable segment of the consumer base.

This financial constraint restricts market penetration by making the procedure unattainable for numerous individuals, irrespective of their growing aesthetic consciousness or desire for rejuvenation. For example, while the overall demand for facial aesthetic procedures remains high, the cost factor influences patient choice significantly. According to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2023, 1,148,559 rhinoplasty (nose reshaping) procedures were performed globally. Despite strong interest in facial enhancements, the elevated price point for platysmaplasty can lead potential patients to defer or opt for less invasive, lower-cost alternatives, thereby hindering the market's ability to achieve its full growth potential and limiting the volume of high-value surgical procedures.

Key Market Trends

The emergence of "prejuvenation" represents a strategic shift in patient motivation towards proactive aesthetic care, aiming to prevent or delay visible signs of aging in the neck and jawline. This trend observes younger demographics increasingly seeking early, less invasive treatments to maintain youthful contours rather than correcting advanced changes. For example, according to the American Society of Plastic Surgeons, in 2024, neuromodulator injections, a common prejuvenation treatment, increased by 4% to 9.9 million procedures, indicating a rising interest in preventative aesthetics. This philosophy expands the platysmaplasty market by engaging a younger clientele focused on long-term appearance preservation. A 2022 American Academy of Facial Plastic and Reconstructive Surgery survey, published in October 2023, indicated that 78% of its members anticipate a greater emphasis on age prevention starting in the 20s and 30s.

Digital media profoundly influences aesthetic standards, directly impacting patient demand for platysmaplasty. The widespread presence of filtered images and idealized celebrity appearances on platforms like Instagram cultivates specific beauty perceptions, particularly regarding a defined jawline and neck. Patients often consult surgeons with goals inspired by these digital portrayals, seeking procedures to enhance their look for selfies and video calls. This trend is strongly supported by a 2023 American Academy of Facial Plastic and Reconstructive Surgery survey, which found that 72% of facial plastic surgeons reported patients seeking procedures to improve their appearance in social media photos. This phenomenon broadens the market by shaping patient desires for procedures aligning with digitally-influenced beauty ideals.

Segmental Insights

The female segment is the fastest growing within the Global Platysmaplasty Treatment Market, primarily driven by increasing societal emphasis on maintaining a youthful and defined neck and jawline. Women exhibit heightened awareness of available aesthetic procedures and a strong inclination to invest in treatments that enhance their appearance. The pervasive influence of social media and the rise of high-definition digital communication contribute significantly to increased self-consciousness regarding neck aesthetics, consequently boosting demand for targeted interventions. This trend extends to a growing interest in "prejuvenation," where younger females increasingly seek early surgical solutions to address visible signs of aging, transitioning from non-invasive treatments to more lasting aesthetic corrections.

Regional Insights

North America leads the global platysmaplasty treatment market, primarily driven by its highly developed healthcare infrastructure which offers advanced surgical techniques and cutting-edge technologies. The region benefits from a significant patient population actively seeking aesthetic enhancements and a substantial presence of skilled plastic surgeons. This dominance is further supported by a high level of consumer awareness regarding cosmetic procedures and a general societal acceptance of aesthetic interventions. Additionally, factors such as robust disposable incomes and a favorable regulatory environment contribute to North America's established position in the market.

Recent Developments

  • In June 2025, Allergan Aesthetics submitted an application to the U.S. Food and Drug Administration (FDA) for SKINVIVE by JUVÉDERM, seeking approval for its use in improving the appearance of the neck. This regulatory step signals the company's focus on expanding its portfolio of injectable treatments to specifically address neck aesthetics. Such developments contribute to the evolution of minimally invasive options available for patients seeking enhancements in the Global Platysmaplasty Treatment Market, offering alternatives or complements to surgical interventions.

  • In May 2025, Apyx Medical announced it had received FDA clearance for its AYON Body Contouring System. This all-in-one surgical platform integrates capabilities for fat removal, tissue contraction, and electrosurgical procedures. The AYON System's clearance facilitates its commercial launch, expected in the latter half of 2025, marking a significant advancement for companies offering comprehensive surgical solutions within the Global Platysmaplasty Treatment Market by enhancing precision and efficiency for surgeons.

  • In December 2024, InMode's Morpheus8 device was highlighted for its effectiveness in skin tightening and contouring procedures, including those targeting the neck area. This technology, which combines microneedling with radiofrequency energy, delivers heat deep into the skin to stimulate collagen production. Its ability to address deeper skin layers than traditional methods makes it a versatile option for non-surgical solutions in aesthetic treatments for the face, neck, and body. The continued prominence of Morpheus8 underscores its contribution to enhancing neck and jawline aesthetics, a key aspect of the Global Platysmaplasty Treatment Market.

  • In December 2024, Cartessa Aesthetics introduced Everesse, a new monopolar radiofrequency (RF) device, to providers in the United States. Manufactured by the South Korean company Classys, this 6.78MHz system was designed to improve patient comfort during skin lifting and tightening procedures. Its introduction offers a new technological advancement in the non-invasive segment of the Global Platysmaplasty Treatment Market, where skin laxity in the neck and jawline is a common concern addressed by such radiofrequency-based solutions.

Key Market Players

  • Long Island Plastic Surgical Group
  • Dr. Cat Plastic Surgery
  • Nazarian Plastic Surgery
  • Avenue Plastic Surgery
  • Piedmont Plastic Surgery & Dermatology
  • The Istanbul Aesthetic Center
  • The Esthetic Clinics
  • Los Angeles Plastic Surgery Clinic

By Gender

By End-User

By Region

  • Male
  • Female
  • Cosmetic Surgery Clinics
  • Hospitals
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
  • Report Scope:

    In this report, the Global Platysmaplasty Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

    • Platysmaplasty Treatment Market, By Gender:

    o   Male

    o   Female

    • Platysmaplasty Treatment Market, By End-User:

    o   Cosmetic Surgery Clinics

    o   Hospitals

    • Platysmaplasty Treatment Market, By Region:

    o   North America

    §  United States

    §  Canada

    §  Mexico

    o   Europe

    §  France

    §  United Kingdom

    §  Italy

    §  Germany

    §  Spain

    o   Asia Pacific

    §  China

    §  India

    §  Japan

    §  Australia

    §  South Korea

    o   South America

    §  Brazil

    §  Argentina

    §  Colombia

    o   Middle East & Africa

    §  South Africa

    §  Saudi Arabia

    §  UAE

    Competitive Landscape

    Company Profiles: Detailed analysis of the major companies presents in the Global Platysmaplasty Treatment Market.

    Available Customizations:

    Global Platysmaplasty Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players (up to five).

    Global Platysmaplasty Treatment Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

    Table of content

    Table of content

    1.    Product Overview

    1.1.  Market Definition

    1.2.  Scope of the Market

    1.2.1.  Markets Covered

    1.2.2.  Years Considered for Study

    1.2.3.  Key Market Segmentations

    2.    Research Methodology

    2.1.  Objective of the Study

    2.2.  Baseline Methodology

    2.3.  Key Industry Partners

    2.4.  Major Association and Secondary Sources

    2.5.  Forecasting Methodology

    2.6.  Data Triangulation & Validation

    2.7.  Assumptions and Limitations

    3.    Executive Summary

    3.1.  Overview of the Market

    3.2.  Overview of Key Market Segmentations

    3.3.  Overview of Key Market Players

    3.4.  Overview of Key Regions/Countries

    3.5.  Overview of Market Drivers, Challenges, Trends

    4.    Voice of Customer

    5.    Global Platysmaplasty Treatment Market Outlook

    5.1.  Market Size & Forecast

    5.1.1.  By Value

    5.2.  Market Share & Forecast

    5.2.1.  By Gender (Male, Female)

    5.2.2.  By End-User (Cosmetic Surgery Clinics, Hospitals)

    5.2.3.  By Region

    5.2.4.  By Company (2024)

    5.3.  Market Map

    6.    North America Platysmaplasty Treatment Market Outlook

    6.1.  Market Size & Forecast

    6.1.1.  By Value

    6.2.  Market Share & Forecast

    6.2.1.  By Gender

    6.2.2.  By End-User

    6.2.3.  By Country

    6.3.    North America: Country Analysis

    6.3.1.    United States Platysmaplasty Treatment Market Outlook

    6.3.1.1.  Market Size & Forecast

    6.3.1.1.1.  By Value

    6.3.1.2.  Market Share & Forecast

    6.3.1.2.1.  By Gender

    6.3.1.2.2.  By End-User

    6.3.2.    Canada Platysmaplasty Treatment Market Outlook

    6.3.2.1.  Market Size & Forecast

    6.3.2.1.1.  By Value

    6.3.2.2.  Market Share & Forecast

    6.3.2.2.1.  By Gender

    6.3.2.2.2.  By End-User

    6.3.3.    Mexico Platysmaplasty Treatment Market Outlook

    6.3.3.1.  Market Size & Forecast

    6.3.3.1.1.  By Value

    6.3.3.2.  Market Share & Forecast

    6.3.3.2.1.  By Gender

    6.3.3.2.2.  By End-User

    7.    Europe Platysmaplasty Treatment Market Outlook

    7.1.  Market Size & Forecast

    7.1.1.  By Value

    7.2.  Market Share & Forecast

    7.2.1.  By Gender

    7.2.2.  By End-User

    7.2.3.  By Country

    7.3.    Europe: Country Analysis

    7.3.1.    Germany Platysmaplasty Treatment Market Outlook

    7.3.1.1.  Market Size & Forecast

    7.3.1.1.1.  By Value

    7.3.1.2.  Market Share & Forecast

    7.3.1.2.1.  By Gender

    7.3.1.2.2.  By End-User

    7.3.2.    France Platysmaplasty Treatment Market Outlook

    7.3.2.1.  Market Size & Forecast

    7.3.2.1.1.  By Value

    7.3.2.2.  Market Share & Forecast

    7.3.2.2.1.  By Gender

    7.3.2.2.2.  By End-User

    7.3.3.    United Kingdom Platysmaplasty Treatment Market Outlook

    7.3.3.1.  Market Size & Forecast

    7.3.3.1.1.  By Value

    7.3.3.2.  Market Share & Forecast

    7.3.3.2.1.  By Gender

    7.3.3.2.2.  By End-User

    7.3.4.    Italy Platysmaplasty Treatment Market Outlook

    7.3.4.1.  Market Size & Forecast

    7.3.4.1.1.  By Value

    7.3.4.2.  Market Share & Forecast

    7.3.4.2.1.  By Gender

    7.3.4.2.2.  By End-User

    7.3.5.    Spain Platysmaplasty Treatment Market Outlook

    7.3.5.1.  Market Size & Forecast

    7.3.5.1.1.  By Value

    7.3.5.2.  Market Share & Forecast

    7.3.5.2.1.  By Gender

    7.3.5.2.2.  By End-User

    8.    Asia Pacific Platysmaplasty Treatment Market Outlook

    8.1.  Market Size & Forecast

    8.1.1.  By Value

    8.2.  Market Share & Forecast

    8.2.1.  By Gender

    8.2.2.  By End-User

    8.2.3.  By Country

    8.3.    Asia Pacific: Country Analysis

    8.3.1.    China Platysmaplasty Treatment Market Outlook

    8.3.1.1.  Market Size & Forecast

    8.3.1.1.1.  By Value

    8.3.1.2.  Market Share & Forecast

    8.3.1.2.1.  By Gender

    8.3.1.2.2.  By End-User

    8.3.2.    India Platysmaplasty Treatment Market Outlook

    8.3.2.1.  Market Size & Forecast

    8.3.2.1.1.  By Value

    8.3.2.2.  Market Share & Forecast

    8.3.2.2.1.  By Gender

    8.3.2.2.2.  By End-User

    8.3.3.    Japan Platysmaplasty Treatment Market Outlook

    8.3.3.1.  Market Size & Forecast

    8.3.3.1.1.  By Value

    8.3.3.2.  Market Share & Forecast

    8.3.3.2.1.  By Gender

    8.3.3.2.2.  By End-User

    8.3.4.    South Korea Platysmaplasty Treatment Market Outlook

    8.3.4.1.  Market Size & Forecast

    8.3.4.1.1.  By Value

    8.3.4.2.  Market Share & Forecast

    8.3.4.2.1.  By Gender

    8.3.4.2.2.  By End-User

    8.3.5.    Australia Platysmaplasty Treatment Market Outlook

    8.3.5.1.  Market Size & Forecast

    8.3.5.1.1.  By Value

    8.3.5.2.  Market Share & Forecast

    8.3.5.2.1.  By Gender

    8.3.5.2.2.  By End-User

    9.    Middle East & Africa Platysmaplasty Treatment Market Outlook

    9.1.  Market Size & Forecast

    9.1.1.  By Value

    9.2.  Market Share & Forecast

    9.2.1.  By Gender

    9.2.2.  By End-User

    9.2.3.  By Country

    9.3.    Middle East & Africa: Country Analysis

    9.3.1.    Saudi Arabia Platysmaplasty Treatment Market Outlook

    9.3.1.1.  Market Size & Forecast

    9.3.1.1.1.  By Value

    9.3.1.2.  Market Share & Forecast

    9.3.1.2.1.  By Gender

    9.3.1.2.2.  By End-User

    9.3.2.    UAE Platysmaplasty Treatment Market Outlook

    9.3.2.1.  Market Size & Forecast

    9.3.2.1.1.  By Value

    9.3.2.2.  Market Share & Forecast

    9.3.2.2.1.  By Gender

    9.3.2.2.2.  By End-User

    9.3.3.    South Africa Platysmaplasty Treatment Market Outlook

    9.3.3.1.  Market Size & Forecast

    9.3.3.1.1.  By Value

    9.3.3.2.  Market Share & Forecast

    9.3.3.2.1.  By Gender

    9.3.3.2.2.  By End-User

    10.    South America Platysmaplasty Treatment Market Outlook

    10.1.  Market Size & Forecast

    10.1.1.  By Value

    10.2.  Market Share & Forecast

    10.2.1.  By Gender

    10.2.2.  By End-User

    10.2.3.  By Country

    10.3.    South America: Country Analysis

    10.3.1.    Brazil Platysmaplasty Treatment Market Outlook

    10.3.1.1.  Market Size & Forecast

    10.3.1.1.1.  By Value

    10.3.1.2.  Market Share & Forecast

    10.3.1.2.1.  By Gender

    10.3.1.2.2.  By End-User

    10.3.2.    Colombia Platysmaplasty Treatment Market Outlook

    10.3.2.1.  Market Size & Forecast

    10.3.2.1.1.  By Value

    10.3.2.2.  Market Share & Forecast

    10.3.2.2.1.  By Gender

    10.3.2.2.2.  By End-User

    10.3.3.    Argentina Platysmaplasty Treatment Market Outlook

    10.3.3.1.  Market Size & Forecast

    10.3.3.1.1.  By Value

    10.3.3.2.  Market Share & Forecast

    10.3.3.2.1.  By Gender

    10.3.3.2.2.  By End-User

    11.    Market Dynamics

    11.1.  Drivers

    11.2.  Challenges

    12.    Market Trends & Developments

    12.1.  Merger & Acquisition (If Any)

    12.2.  Product Launches (If Any)

    12.3.  Recent Developments

    13.    Global Platysmaplasty Treatment Market: SWOT Analysis

    14.    Porter's Five Forces Analysis

    14.1.  Competition in the Industry

    14.2.  Potential of New Entrants

    14.3.  Power of Suppliers

    14.4.  Power of Customers

    14.5.  Threat of Substitute Products

    15.    Competitive Landscape

    15.1.  Long Island Plastic Surgical Group

    15.1.1.  Business Overview

    15.1.2.  Products & Services

    15.1.3.  Recent Developments

    15.1.4.  Key Personnel

    15.1.5.  SWOT Analysis

    15.2.  Dr. Cat Plastic Surgery

    15.3.  Nazarian Plastic Surgery

    15.4.  Avenue Plastic Surgery

    15.5.  Piedmont Plastic Surgery & Dermatology

    15.6.  The Istanbul Aesthetic Center

    15.7.  The Esthetic Clinics

    15.8.  Los Angeles Plastic Surgery Clinic

    16.    Strategic Recommendations

    17.    About Us & Disclaimer

    Figures and Tables

    Frequently asked questions

    Frequently asked questions

    The market size of the Global Platysmaplasty Treatment Market was estimated to be USD 1.93 Billion in 2024.

    North America is the dominating region in the Global Platysmaplasty Treatment Market.

    Female segment is the fastest growing segment in the Global Platysmaplasty Treatment Market.

    The Global Platysmaplasty Treatment Market is expected to grow at 6.33% between 2025 to 2030.

    Related Reports

    We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.